Ignition of calcium sparks in arterial and cardiac muscle through caveolae.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 11090549)

Published in Circ Res on November 24, 2000

Authors

M Löhn1, M Fürstenau, V Sagach, M Elger, W Schulze, F C Luft, H Haller, M Gollasch

Author Affiliations

1: Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine, Charité University Hospitals, Humboldt University of Berlin, Germany.

Articles citing this

Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci U S A (2006) 2.76

The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol (2004) 2.70

Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol (2008) 2.57

Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet (2010) 1.62

Caveolin-3 is adjacent to a group of extradyadic ryanodine receptors. Biophys J (2005) 1.49

Crosstalk between ryanodine receptors and IP(3) receptors as a factor shaping spontaneous Ca(2+)-release events in rabbit portal vein myocytes. J Physiol (2002) 1.46

Role of the transverse-axial tubule system in generating calcium sparks and calcium transients in rat atrial myocytes. J Physiol (2003) 1.45

Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells. J Biol Chem (2008) 1.40

Excitation-contraction coupling changes during postnatal cardiac development. J Mol Cell Cardiol (2009) 1.36

Caveolae, ion channels and cardiac arrhythmias. Prog Biophys Mol Biol (2009) 1.35

A 3D Monte Carlo analysis of the role of dyadic space geometry in spark generation. Biophys J (2005) 1.34

Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction. J Biol Chem (2005) 1.23

Characteristics and function of cardiac mitochondrial nitric oxide synthase. J Physiol (2008) 1.20

Indirect coupling between Cav1.2 channels and ryanodine receptors to generate Ca2+ sparks in murine arterial smooth muscle cells. J Physiol (2007) 1.20

'Pressure-flow'-triggered intracellular Ca2+ transients in rat cardiac myocytes: possible mechanisms and role of mitochondria. J Physiol (2008) 1.15

Large conductance, Ca2+-activated K+ channels (BKCa) and arteriolar myogenic signaling. FEBS Lett (2010) 1.10

Regional differences in spontaneous Ca2+ spark activity and regulation in cat atrial myocytes. J Physiol (2006) 1.06

Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J Mol Cell Cardiol (2011) 1.05

Genetic ablation of caveolin-1 modifies Ca2+ spark coupling in murine arterial smooth muscle cells. Am J Physiol Heart Circ Physiol (2006) 1.02

Membrane cholesterol regulates smooth muscle phasic contraction. J Membr Biol (2004) 1.01

Caveolin-1 assembles type 1 inositol 1,4,5-trisphosphate receptors and canonical transient receptor potential 3 channels into a functional signaling complex in arterial smooth muscle cells. J Biol Chem (2010) 0.99

Caveolin-1 and force regulation in porcine airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2011) 0.99

Heterogeneous function of ryanodine receptors, but not IP3 receptors, in hamster cremaster muscle feed arteries and arterioles. Am J Physiol Heart Circ Physiol (2011) 0.98

Caveolins in vascular smooth muscle: form organizing function. Cardiovasc Res (2006) 0.96

Localization of sarcolemmal proteins to lipid rafts in the myocardium. Cell Calcium (2007) 0.95

Calcium signalling through nucleotide receptor P2X1 in rat portal vein myocytes. J Physiol (2001) 0.95

Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells. J Physiol (2004) 0.93

Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells. PLoS One (2013) 0.90

Caveolins: targeting pro-survival signaling in the heart and brain. Front Physiol (2012) 0.89

Lipid raft in cardiac health and disease. Curr Cardiol Rev (2009) 0.89

Caveolin 3 is associated with the calcium release complex and is modified via in vivo triadin modification. Biochemistry (2010) 0.87

Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes. J Physiol (2005) 0.86

Cardiac myocytes and local signaling in nano-domains. Prog Biophys Mol Biol (2011) 0.85

Sorcin modulation of Ca2+ sparks in rat vascular smooth muscle cells. J Physiol (2006) 0.85

Three dimensional neuronal cell cultures more accurately model voltage gated calcium channel functionality in freshly dissected nerve tissue. PLoS One (2012) 0.85

Muscarinic receptor-mediated bronchoconstriction is coupled to caveolae in murine airways. Am J Physiol Lung Cell Mol Physiol (2009) 0.84

Direct Evidence for Microdomain-Specific Localization and Remodeling of Functional L-Type Calcium Channels in Rat and Human Atrial Myocytes. Circulation (2015) 0.84

Disruption of the maxi-K-caveolin-1 interaction alters current expression in human myometrial cells. Reprod Biol Endocrinol (2009) 0.84

Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance. PLoS One (2013) 0.83

Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle (2010) 0.82

Couplons in rat atria form distinct subgroups defined by their molecular partners. J Cell Sci (2011) 0.82

Cholesterol depletion alters coronary artery myocyte Ca(2+) signalling in a stimulus-specific manner. Cell Calcium (2010) 0.82

Caveolin-1 facilitates the direct coupling between large conductance Ca2+-activated K+ (BKCa) and Cav1.2 Ca2+ channels and their clustering to regulate membrane excitability in vascular myocytes. J Biol Chem (2013) 0.82

The relaxant effect of Nigella sativa on smooth muscles, its possible mechanisms and clinical applications. Iran J Basic Med Sci (2014) 0.82

Real-time dynamic movement of caveolin-1 during smooth muscle contraction of human colon and aged rat colon transfected with caveolin-1 cDNA. Am J Physiol Gastrointest Liver Physiol (2011) 0.79

Electrophysiology and metabolism of caveolin-3-overexpressing mice. Basic Res Cardiol (2016) 0.78

Mechanism of vasorelaxation induced by Achillea wilhelmsii in rat isolated thoracic aorta. Adv Biomed Res (2014) 0.78

Endothelium-independent vasorelaxant effects of hydroalcoholic extract from Nigella sativa seed in rat aorta: the roles of Ca2+ and K+ channels. Biomed Res Int (2014) 0.77

Measuring fast calcium fluxes in cardiomyocytes. J Vis Exp (2011) 0.76

Cholesterol is required for maintaining T-tubule integrity and intercellular connections at intercalated discs in cardiomyocytes. J Mol Cell Cardiol (2016) 0.75

Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology. Am J Physiol Cell Physiol (2017) 0.75

Caveolar disruption causes contraction of rat femoral arteries via reduced basal NO release and subsequent closure of BKCa channels. PeerJ (2015) 0.75

Microdomain-specific localization of functional ion channels in cardiomyocytes: an emerging concept of local regulation and remodelling. Biophys Rev (2015) 0.75

Articles by these authors

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53

Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23

Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99

Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28

Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development (1998) 3.07

Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother (1976) 2.98

Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis (1974) 2.93

Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca(2+) spark/STOC coupling and elevated blood pressure. Circ Res (2000) 2.76

AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57

Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension (1986) 2.51

Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol Cell Biol (1999) 2.27

Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26

Infiltrates in protocol biopsies from renal allografts. Am J Transplant (2007) 2.24

Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22

Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22

Experimental aminoglycoside nephrotoxicity. J Lab Clin Med (1975) 2.19

Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation (1979) 2.15

Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxford) (2008) 2.11

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension (2000) 2.06

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension (2001) 2.04

Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family. FEBS Lett (1997) 2.03

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant (1996) 2.01

Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med (2001) 2.00

SUT2, a putative sucrose sensor in sieve elements. Plant Cell (2000) 1.97

Ca2+ channels, ryanodine receptors and Ca(2+)-activated K+ channels: a functional unit for regulating arterial tone. Acta Physiol Scand (1998) 1.91

Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res (2001) 1.88

Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med (1998) 1.86

Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis (1995) 1.85

Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis (1978) 1.83

Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol (2001) 1.75

Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother (1975) 1.72

Overnight urine collections to estimate sodium intake. Hypertension (1983) 1.58

Twin zygosity. Automated determination with microsatellites. J Reprod Med (1997) 1.53

Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int (1995) 1.53

Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med (Berl) (2001) 1.51

Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn (1998) 1.50

Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis (1992) 1.49

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest (2003) 1.49

Time for action. Arch Intern Med (1991) 1.48

Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J (1998) 1.48

Nephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother (1976) 1.45

Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant (1997) 1.45

Right-sided chest pain at the onset of haemodialysis. Nephrol Dial Transplant (2001) 1.44

A region on chromosome 3 is linked to dizygotic twinning. Nat Genet (2000) 1.44

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43

Kidneys from pediatric donors: risk versus benefit. Clin Nephrol (1994) 1.39

The tell-tale urinary chloride. Nephrol Dial Transplant (2001) 1.39

Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis (1980) 1.38

STOPPING at the CAPPP of good HOPE. Nephrol Dial Transplant (2000) 1.38

A left-to-left shunt. Am J Med (1999) 1.38

Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36

Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant (2011) 1.36

Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35

A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant (1999) 1.35

Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res (1996) 1.34

Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34

Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension (1999) 1.32

Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension (1999) 1.30

Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol (2001) 1.29

Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal insufficiency. Soc Sci Med (1995) 1.29

Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26

The role of podocytes in the development of glomerular sclerosis. Kidney Int Suppl (1994) 1.26

Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int (2006) 1.23

Trauma involving the proximal tibial epiphysis. Arch Orthop Trauma Surg (1991) 1.23

Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci (2000) 1.23

Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (2001) 1.23

Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet (1996) 1.22

From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J (1997) 1.21

A role for podocytes to counteract capillary wall distension. Kidney Int (1994) 1.21

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study. Int J Clin Pract (2011) 1.20

L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J (1998) 1.20

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension (2001) 1.19

Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant (1999) 1.19

Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension (1983) 1.19

QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation (1999) 1.18

STUDIES OF COPROPORPHYRIN. III. IDIOPATHIC COPROPORPHYRINURIA; A HITHERTO UNRECOGNIZED FORM CHARACTERIZED BY LACK OF SYMPTOMS IN SPITE OF THE EXCRETION OF LARGE AMOUNTS OF COPROPORPHYRIN. J Clin Invest (1949) 1.18

Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure. Antimicrob Agents Chemother (1977) 1.18

Minoxidil treatment of malignant hypertension. Recovery of renal function. JAMA (1978) 1.17

Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother (1981) 1.17

Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther (1983) 1.16

The Diabetes Intervention Study (DIS): a cooperative multi-intervention trial with newly manifested type II diabetics: preliminary results. Monogr Atheroscler (1985) 1.15

Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int (1996) 1.15